{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:39:53Z","timestamp":1790498393892,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Avon","award":["#02-2013-044"],"award-info":[{"award-number":["#02-2013-044"]}]},{"name":"NIH\/NCI","award":["#RC4 CA153828-01"],"award-info":[{"award-number":["#RC4 CA153828-01"]}]},{"name":"Fundo de Incentivo a Pesquisa e Eventos"},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cancergen.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T18:37:22Z","timestamp":1467052642000},"page":"417-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations"],"prefix":"10.1016","volume":"209","author":[{"given":"B\u00e1rbara","family":"Alemar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Brinckmann Oliveira Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Artigal\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Vanessa D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Matzenbacher Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ashton-Prolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.06.008_bib0010","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0015","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0020","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S1470-2045(11)70323-0","article-title":"Breast cancer in Brazil: present status and future goals","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0025","series-title":"Estimativa 2016: Incid\u00eancia de C\u00e2ncer no Brasil (Estimate\/2016\u2014Cancer Incidence in Brazil)","year":"2015"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0030","first-page":"1","article-title":"Concise handbook of familial cancer susceptibility syndromes\u2014second edition","author":"Lindor","year":"2008","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0035","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0040","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0045","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","article-title":"Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer","volume":"31","author":"Castro","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bjc.6604453","article-title":"Rapid progression of prostate cancer in men with a BRCA2 mutation","volume":"99","author":"Narod","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1897-4287-12-11","article-title":"Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medell\u00edn, Colombia","volume":"12","author":"Hern\u00e1ndez","year":"2014","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2011.10.027","article-title":"BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia","volume":"124","author":"Rodr\u00edguez","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0065","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.24200","article-title":"BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer","volume":"115","author":"Hall","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","article-title":"Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network","volume":"31","author":"Weitzel","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0075","first-page":"327","article-title":"Genetics, genomics and cancer risk assessment: state of the art and future directions in the era of personalized medicine","volume":"61","author":"Weitzel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/GIM.0b013e31821882b7","article-title":"Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce","volume":"13","author":"Blazer","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0085","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1996.14.5.1730","article-title":"Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996","volume":"14","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0090","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0095","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cncr.29058","article-title":"Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico","volume":"121","author":"Villarreal-Garza","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1590\/S1516-31802005000400007","article-title":"Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history","volume":"123","author":"Dufloth","year":"2005","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-006-9378-6","article-title":"Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil","volume":"103","author":"Gomes","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1590\/S0100-879X2009000500009","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil","volume":"42","author":"Esteves","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057581","article-title":"Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil","volume":"8","author":"Carraro","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2350-15-55","article-title":"Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients","volume":"15","author":"Silva","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0135","doi-asserted-by":"crossref","first-page":"14012","DOI":"10.1038\/hgv.2014.12","article-title":"Germline mutations in BRCA1, BRCA1, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population","volume":"1","author":"Felix","year":"2014","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cge.12505","article-title":"Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru","volume":"88","author":"Abugattas","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037432","article-title":"Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer","volume":"7","author":"Vaca-Paniagua","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2193-1801-1-20","article-title":"BRCA1 and BRCA2 analysis of Argentinean breast\/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin","volume":"1","author":"Solano","year":"2012","journal-title":"Springerplus"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-006-9370-1","article-title":"High proportion of BRCA1\/2 founder mutations in Hispanic breast\/ovarian cancer families from Colombia","volume":"103","author":"Torres","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-005-9047-1","article-title":"Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast\/ovarian cancer, genotype-phenotype correlations","volume":"95","author":"Gallardo","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10549-010-1170-y","article-title":"Spectrum of BRCA1\/2 point mutations and genomic rearrangements in high-risk breast\/ovarian cancer Chilean families","volume":"126","author":"Gonzalez-Hormazabal","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-010-1320-2","article-title":"BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants","volume":"128","author":"Delgado","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0175","first-page":"505","article-title":"The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women","volume":"60","author":"Abeliovich","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0185","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ejhg.2010.203","article-title":"On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations","volume":"19","author":"Hamel","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S1415-47572004000400006","article-title":"BRCA1 mutations in Brazilian patients","author":"Louren\u00e7o","year":"2004","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cancergencyto.2008.03.011","article-title":"Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome","volume":"184","author":"da Costa","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0200","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","article-title":"Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes","volume":"25","author":"Machado","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","article-title":"Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects","volume":"22","author":"D\u00edez","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0210","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/301885","article-title":"Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study","volume":"62","author":"Neuhausen","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.breast.2008.05.001","article-title":"Counseling for male BRCA mutation carriers: a review","volume":"17","author":"Mohamad","year":"2008","journal-title":"Breast"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","article-title":"Epidemiology of male breast cancer","volume":"14","author":"Weiss","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0225","first-page":"313","article-title":"Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population","volume":"60","author":"Friedman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2016.06.008_bib0230","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am J Hum Genet"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:05Z","timestamp":1761896465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216302083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2210776216302083"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.008","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}